GRIN2A mutation is a novel indicator of stratifying beneficiaries of immune checkpoint inhibitors in multiple cancers

Cancer Gene Therapy, Published online: 24 January 2024; doi:10.1038/s41417-024-00730-6GRIN2A mutation is a novel indicator of stratifying beneficiaries of immune checkpoint inhibitors in multiple cancers

Source: Cancer Gene Therapy - January 24, 2024 Category: Cancer & Oncology Authors: Gan-xun Li Rui-zhi Chang Tong-tong Liu Guan-nan Jin Kan Lu Tu-ying Yong Zifu Li Ji-hong Liu Bixiang Zhang Wan-guang Zhang Ze-yang Ding Source Type: research